SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (23)7/11/2001 2:30:28 PM
From: scaram(o)uche  Read Replies (1) of 269
 
parking, not out yet..... we should revisit this issue in a couple of weeks, and paste the abstract here.......

Point mutation in essential genes with loss or mutation of the second
allele: relevance to the retention of tumor-specific antigens
G.B. Beck-Engeser, P.A. Monach, D. Mumberg, F. Yang, S.
Wanderling,
K. Schreiber, R. Espinosa , M.M. Le Beau, S.C. Meredith, and H.
Schreiber
J. Exp. Med. 2001 194 (3)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News